These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32827494)

  • 41. Review - An update on the use of oral phospholipid excipients.
    van Hoogevest P
    Eur J Pharm Sci; 2017 Oct; 108():1-12. PubMed ID: 28711714
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulating Drug Release and Enhancing the Oral Bioavailability of Torcetrapib with Solid Lipid Dispersion Formulations.
    Liu Y; Salituro GM; Lee KJ; Bak A; Leung DH
    AAPS PharmSciTech; 2015 Oct; 16(5):1091-100. PubMed ID: 25690735
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preparation and evaluation of celecoxib-loaded proliposomes with high lipid content.
    Jeon D; Kim KT; Baek MJ; Kim DH; Lee JY; Kim DD
    Eur J Pharm Biopharm; 2019 Aug; 141():139-148. PubMed ID: 31150807
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetic aspects and in vitro-in vivo correlation potential for lipid-based formulations.
    Kollipara S; Gandhi RK
    Acta Pharm Sin B; 2014 Oct; 4(5):333-49. PubMed ID: 26579403
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Formulation of Dronedarone Hydrochloride-Loaded Proliposomes: In Vitro and In Vivo Evaluation Using Caco-2 and Rat Model.
    Kovvasu SP; Kunamaneni P; Yeung S; Rueda J; Betageri GV
    AAPS PharmSciTech; 2019 Jun; 20(6):226. PubMed ID: 31214813
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of aminoalkyl methacrylate copolymer E/HCl on in vivo absorption of poorly water-soluble drug.
    Yoshida T; Kurimoto I; Yoshihara K; Umejima H; Ito N; Watanabe S; Sako K; Kikuchi A
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1698-705. PubMed ID: 23062024
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amorphous Solid Dispersions or Prodrugs: Complementary Strategies to Increase Drug Absorption.
    Rumondor ACF; Dhareshwar SS; Kesisoglou F
    J Pharm Sci; 2016 Sep; 105(9):2498-2508. PubMed ID: 26886316
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Simultaneous Evaluation of Dissolution and Permeation of Oral Drug Solid Formulations for Predicting Absorption Rate-Limiting Factors and In Vitro-In Vivo Correlations: Case Study Using a Poorly Soluble Weakly Basic Drug.
    Li Z; He X; Tian S; Feng G; Huang C; Xun M; Wu Z; Wang Y
    AAPS PharmSciTech; 2019 Oct; 20(8):321. PubMed ID: 31650430
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polymer/lipid interplay in altering in vitro supersaturation and plasma concentration of a model poorly soluble drug.
    Peng R; Huang J; He L; Zhao L; Wang C; Wei W; Xia T; Mao Y; Wen Y; Wang L; Yang J
    Eur J Pharm Sci; 2020 Apr; 146():105262. PubMed ID: 32060005
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetic Evaluation of Improved Oral Bioavailability of Valsartan: Proliposomes Versus Self-Nanoemulsifying Drug Delivery System.
    Nekkanti V; Wang Z; Betageri GV
    AAPS PharmSciTech; 2016 Aug; 17(4):851-62. PubMed ID: 26381913
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of lipid-based excipients and their composition on the bioavailability of antiretroviral self-emulsifying formulations.
    Chudasama A; Patel V; Nivsarkar M; Vasu K; Shishoo C
    Drug Deliv; 2015; 22(4):531-40. PubMed ID: 24601856
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Danazol oral absorption modelling in the fasted dog: An example of mechanistic understanding of formulation effects on drug pharmacokinetics.
    Pade D; Jamei M; Turner DB; Mistry B; Martinez MN
    Eur J Pharm Biopharm; 2019 Aug; 141():191-209. PubMed ID: 31150808
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Formulation, characterization, and in vivo evaluation of celecoxib-PVP solid dispersion nanoparticles using supercritical antisolvent process.
    Ha ES; Choo GH; Baek IH; Kim MS
    Molecules; 2014 Dec; 19(12):20325-39. PubMed ID: 25486246
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro models for the prediction of in vivo performance of oral dosage forms.
    Kostewicz ES; Abrahamsson B; Brewster M; Brouwers J; Butler J; Carlert S; Dickinson PA; Dressman J; Holm R; Klein S; Mann J; McAllister M; Minekus M; Muenster U; Müllertz A; Verwei M; Vertzoni M; Weitschies W; Augustijns P
    Eur J Pharm Sci; 2014 Jun; 57():342-66. PubMed ID: 23988843
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lipidic dispersion to reduce food dependent oral bioavailability of fenofibrate: In vitro, in vivo and in silico assessments.
    O'Shea JP; Faisal W; Ruane-O'Hora T; Devine KJ; Kostewicz ES; O'Driscoll CM; Griffin BT
    Eur J Pharm Biopharm; 2015 Oct; 96():207-16. PubMed ID: 26215636
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of Ingested Water Volume on Oral Absorption of Fenofibrate, a BCS Class II Drug, from Micronized and Amorphous Solid Dispersion Formulations in Rats.
    Kataoka M; Ikkou S; Kato Y; Minami K; Higashino H; Takagi T; Yamashita S
    Biol Pharm Bull; 2022; 45(10):1452-1457. PubMed ID: 36184502
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oral bioavailability enhancement through supersaturation: an update and meta-analysis.
    Fong SY; Bauer-Brandl A; Brandl M
    Expert Opin Drug Deliv; 2017 Mar; 14(3):403-426. PubMed ID: 27488049
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanisms of increased bioavailability through amorphous solid dispersions: a review.
    Schittny A; Huwyler J; Puchkov M
    Drug Deliv; 2020 Dec; 27(1):110-127. PubMed ID: 31885288
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A pH-dilution method for estimation of biorelevant drug solubility along the gastrointestinal tract: application to physiologically based pharmacokinetic modeling.
    Gao Y; Carr RA; Spence JK; Wang WW; Turner TM; Lipari JM; Miller JM
    Mol Pharm; 2010 Oct; 7(5):1516-26. PubMed ID: 20715778
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.
    Ji H; Tang J; Li M; Ren J; Zheng N; Wu L
    Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.